← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Suvalent Therapeutics, Inc.
Newbury Park, CA
$2,755,406
Total funding
4
Grants
Funding over time
peak $1.2M · FY2014–19$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$2,755,406 · 4
By mechanism
R44$1,997,648 · 1
R43$757,758 · 3
Investigators at Suvalent Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Design of a Covalent Inhibitor for c-Myc-Dependent Cancers$1,208,769
R44 · FY2016 · CA
Design of a Covalent Inhibitor for c-Myc-Dependent Cancers$788,879
R44 · FY2015 · CA
Orally available allosteric inhibitor of protein sumoylation$300,000
R43 · FY2019 · CA
Development of an oral drug targeting SUMOylation$232,759
R43 · FY2018 · CA
Design of a Covalent Inhibitor for c-Myc-Dependent Cancers$224,999
R43 · FY2014 · CA